Compare AMRX & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | CRUS |
|---|---|---|
| Founded | 2002 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.4B |
| IPO Year | 2018 | 1997 |
| Metric | AMRX | CRUS |
|---|---|---|
| Price | $19.09 | $107.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $22.71 | ★ $163.33 |
| AVG Volume (30 Days) | ★ 2.9M | 679.0K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | 30.83 |
| EPS | 0.37 | ★ 1.47 |
| Revenue | N/A | ★ $1,997,379,000.00 |
| Revenue This Year | $4.53 | $1.10 |
| Revenue Next Year | $9.13 | $4.75 |
| P/E Ratio | ★ $52.01 | $73.82 |
| Revenue Growth | N/A | ★ 5.34 |
| 52 Week Low | $9.92 | $105.10 |
| 52 Week High | $21.18 | $180.42 |
| Indicator | AMRX | CRUS |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 33.26 |
| Support Level | $16.59 | $106.26 |
| Resistance Level | $19.26 | $123.88 |
| Average True Range (ATR) | 0.62 | 3.55 |
| MACD | -0.19 | -1.06 |
| Stochastic Oscillator | 11.78 | 13.52 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Cirrus Logic Inc is a supplier of low-power, low-latency, high-precision audio components that are used in a variety of applications, including smartphones, PCs, tablets, AR/VR headsets, wearables, home theater systems, automotive entertainment systems, and professional audio systems. The firm's products are organized into two streams: audio products and HPMS Products. These products include amplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters, and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, India, South Korea, and countries across the world.